Combined Resources Bring Key Advantages to Global Aquaculture Sector
GLOBAL - The world's aquaculture market has a new leader in aquatic health. Schering Plough takes premier status, now that the acquisition of Organon Biosciences (Intervet) is complete and resources have been streamlined. It has announced a comprehensive...

Aquaculture Vaccines - 25 Years progress and a vision for the future
GLOBAL - The rapid progress in the development and delivery of fish vaccines for a wide range of species is now providing significant health and economic benefits to world aquaculture, says leading immunologist Professor Patrick Smith.

SP Highlights Vaccination Benefits in SE Asia
HANOI- A series of key aquaculture events and presentations have confirmed Schering-Plough's increasing presence and support in South East Asia.

€11 billion deal seals SP buyout
NEW JERSEY - Schering-Plough Corporation has completed the acquisition of Organon BioSciences from Akzo Nobel. The deal has cost the company approximately Euro 11 billion in cash and creates the world's largest animal health organisation.

AQUAFLOR® Approved for Controlling Mortality Due to Furunculosis in Freshwater-Reared Salmonids
USA - AQUAFLOR® (florfenicol), the fast-acting in-feed antibiotic developed by Schering-Plough Animal Health Corporation, has been approved by the U.S. Food and Drug Administration (FDA) for control of mortality in freshwater-reared salmonids due to furunculosis...

Euro approval for the World's largest animal health business
EUROPE - Schering-Plough Corporation has received European Commission approval for its planned acquisition of Organon BioSciences, from Akzo Nobel.

First and only catfish antibiotic approved for Columnaris
US - Schering-Plough Animal Health Corporation has introduced AQUAFLOR^®-CA1 (florfenicol), the first and only in-feed antibiotic conditionally approved for the control of mortality in catfish due to columnaris disease associated with Flavobacterium...

Schering-Plough acknowledged for work developing vaccinations
UK - Schering-Plough have been shortlisted for an Aquaculture Today Fit for the Future award for innovation in aquaculture.

Reminder to boost as ERM vaccination season starts
UK - Trout farmers are being reminded of the benefits of planning an oral boost to follow immersion vaccination for ERM this season. The oral boost is intended to extend the protection induced by primary immersion vaccination. It is included in feed and...

New in-feed antibiotic approved for freshwater-reared Salmonids
US - AQUAFLOR® (florfenicol), the first new in-feed antibiotic licensed for U.S. aquaculture in more than two decades, has become the first and only antibiotic approved for controlling mortality in freshwater-reared salmonids due to Flavobacterium psychrophilum...

Schering-Plough buy Intervet Animal Health Business
NETHERLANDS - American based company Schering-Plough has announced it is to acquire the Dutch veterinary company Intervet as part of its buy out of Organon BioSciences, the pharmaceutical division of chemical company Akzo Nobel.

Schering-Plough Animal Health's AquaVac RELERA Gains Authorisation
UK - Schering-Plough Animal Health announces provisional marketing authorisation for AquaVac* RELERA*, a bivalent vaccine providing protection against ERM (Enteric Redmouth) caused by Hagerman Type 1 and the new EX5 biogroup strains of Yersinia rucke...

Schering-Plough Aquaculture appoints new UK sales manager
UK - Schering-Plough Aquaculture has strengthened its UK operation with the appointment of a new national sales manager. Keith Morris, currently project manager with the company’s R&D department, will take responsibility for growing and supporting the...

FDA’s Approval of AQUAFLOR Marks New Era in Teamwork
US - The U.S. Food and Drug Administration’s recent approval of AQUAFLORâ (florfenicol) Type A Medicated Article for catfish marked a significant milestone in the industry’s combined efforts to make more products available for public and commercial ...

FDA's Approval of AQUAFLOR Marks New Era in Teamwork
US - The U.S. Food and Drug Administration's recent approval of AQUAFLOR (florfenicol) Type A Medicated Article for catfish marked a significant milestone in the industry's combined efforts to make more products available for public and commercial...

Dogs and Catfish?
US - Companion and large-animal veterinarians near major catfish-production areas of the United States may want to bone up on aquatic diseases to help meet the expected surge in demand for veterinary services.

Scottish Workshop Explores Ways To Optimise Treatment Strategies for Sea Lice in Farmed Salmon
GLOBAL - Forty aquaculture industry professionals gathered here recently to discuss treatment of sea lice, a costly parasite to fish farms. The meeting focused on treatment through the use medicated feed, with emphasis on optimization of treatment practices...

Schering-Plough Animal Health Commemorates 50th Anniversary
GLOBAL - Schering-Plough Animal Health Corp. (SPAH), a global leader in advancing the health and welfare of animals, is celebrating its 50th anniversary today.

Schering-Plough Animal Health Names Kasha M. Cox Territory Manager, U.S. Aquaculture
GLOBAL – Schering-Plough Animal Health Corporation has appointed Kasha M. Cox as Territory Manager for U.S. Aquaculture.

Schering-Plough Animal Health Names Haacke Marketing Manager, Global Aquaculture
GLOBAL – Schering-Plough Animal Health Corporation’s has appointed Chris Haacke to the position of Marketing Manager, Global Aquaculture. Based at Schering-Plough Aquaculture’s European office in Saffron Walden, England, Haacke will work with the company’s...

First fish vaccine ever to be approved through the EU's Mutual Recognition procedure
EU – Schering Plough Animal Health's dedicated Aquaculture business unit has recently received approval of their vaccine for the protection of Rainbow Trout from Enteric Red Mouth Disease (Yersiniosis) through the European Union's mutual recognition...

Leading Vet joins Schering-Plough Aquaculture Division
UK - Schering-Plough Animal Health announces the appointment of David Schofield MRCVS as Business Director for the Aquaculture and Poultry division in the UK.